What are the presentations, symptoms, and treatments of Transfusion-Associated Circulatory Overload (TACO) and Transfusion-Related Acute Lung Injury (TRALI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

TACO and TRALI: Presentations, Symptoms, and Treatments

Both Transfusion-Associated Circulatory Overload (TACO) and Transfusion-Related Acute Lung Injury (TRALI) present with respiratory distress within hours of transfusion, but TACO is characterized by fluid overload with cardiovascular changes while TRALI is a non-cardiogenic pulmonary edema requiring immediate cessation of transfusion and supportive care. 1

Transfusion-Associated Circulatory Overload (TACO)

Presentation and Symptoms

  • TACO is now the most common cause of transfusion-related mortality and major morbidity 1
  • Occurs during or up to 12 hours after transfusion 1
  • Key clinical features include:
    • Acute or worsening respiratory compromise 1
    • Acute or worsening pulmonary edema 1
    • Cardiovascular changes (tachycardia, hypertension) not explained by underlying condition 1
    • Evidence of fluid overload 1
    • Elevated brain natriuretic peptide (BNP) levels 1, 2

Risk Factors

  • Older patients (age >70 years) 1
  • Non-bleeding patients 1
  • Comorbidities: heart failure, renal failure, hypoalbuminemia 1
  • Low body weight 1
  • Rapid transfusion 1
  • Positive fluid balance 2

Treatment

  • Immediate cessation of transfusion 1
  • Diuretic therapy 1, 3
  • Supplemental oxygen 3
  • Phlebotomy in severe cases 3
  • Slow transfusion rates for future transfusions 1
  • Body weight-based dosing of blood products 1

Transfusion-Related Acute Lung Injury (TRALI)

Presentation and Symptoms

  • Non-cardiogenic pulmonary edema resulting from immune reactivity 1
  • Signs and symptoms appear 1-2 hours after transfusion and reach maximum intensity within 6 hours 1
  • Key clinical features include:
    • Hypoxemia 1
    • Fever 1
    • Dyspnea 1
    • Bilateral pulmonary infiltrates 2
    • Fluid in the endotracheal tube may occur 1
    • Increased peak airway pressure in ventilated patients 1

Risk Factors

  • No specific patient profile has been identified as high risk 3
  • Associated with all blood components, but most commonly with plasma-containing products 3
  • Caused by donor antibodies (usually HLA or granulocyte-specific) interacting with recipient antigens 1

Treatment

  • Immediate cessation of transfusion 1
  • Critical care supportive measures 1
  • Oxygen therapy 2
  • Mechanical ventilation if necessary 2
  • No specific therapy beyond supportive care 1
  • Most patients recover within 96 hours 1, 3

Distinguishing Between TACO and TRALI

Key Differences

  • TACO is cardiogenic (hydrostatic) pulmonary edema 2, 4
  • TRALI is non-cardiogenic (permeability) pulmonary edema 2, 4
  • TACO typically presents with hypertension, while TRALI does not 1, 2
  • Elevated BNP levels suggest TACO rather than TRALI 1, 2
  • TRALI more commonly presents with fever 1

Monitoring for Transfusion Reactions

  • Monitor respiratory rate throughout transfusion (early indicator of serious reactions) 1
  • Record vital signs before transfusion, 15 minutes after starting, and within 60 minutes of completion 1
  • Check for signs and symptoms periodically during transfusion 1
  • Assess urine output and color 1
  • Monitor peak airway pressure in ventilated patients 1

Prevention Strategies

TACO Prevention

  • Assess need for transfusion carefully 1
  • Use body weight-based dosing of blood products 1
  • Transfuse slowly in high-risk patients 1
  • Monitor vital signs and fluid balance closely 1
  • Consider prophylactic diuretics in high-risk patients 1

TRALI Prevention

  • Blood banks have implemented measures to reduce TRALI risk 1
  • Screening of donors for leukocyte antibodies 2
  • Using male-only plasma donors has reduced TRALI incidence 5

Important Considerations

  • Both conditions can be life-threatening and require prompt recognition 2
  • Distinguishing between TACO and TRALI can be challenging but is crucial for appropriate management 4
  • Some patients may present with features of both conditions simultaneously 5
  • Bacterial contamination of blood products can present with similar symptoms (fever, respiratory distress) and should be considered in the differential diagnosis 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Transfusion and lung injury.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine, 2001

Research

[TRALI and TACO: diagnostic and clinical management of patients].

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.